CM336-SOC for Dynamically High-Risk Multiple Myeloma Study
Clinical trial NCT07648459 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07648459
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-07-09
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.